Account Executive @ (January 2023 - December 2025)
Territory Sales Executive @ Cepheid (November 2021 - January 2023)
Senior Territory Manager @ (March 2016 - November 2021)
Senior Vaccines Solutions Specialist @ (January 2011 - August 2015)
Oncology Sales Representative @ (July 2006 - February 2009)
Senior Pharmaceutical Sales Representative @ (January 2004 - June 2006)
Pharmaceutical Sales Representative @ (March 2001 - December 2003)
Melissa Porter Education
Louisiana State University
Bachelor of Arts - BA
University of New Orleans
Master of Arts - MA
Melissa Porter Skills
Account Management
Biotechnology
Building Relationships
Business-to-Business (B2B)
Buy & Bill
Capital Equipment
Cardiology
Consultative Selling
Cross-functional Team Leadership
Dermatology
Direct Sales
Epilepsy
Genetic Testing
Healthcare Reimbursement
Hospital Sales
Immunology
Infectious Diseases
Injections
Laboratory Equipment
Leadership
Managed Care
Market Access
Medical Sales
Mental Health
Molecular Diagnostics
Mood Disorders
Networking
New Business Development
Oncology
Orthopedics
Osteoarthritis
Pain Management
Pediatrics
Pharmaceutical Industry
Pharmaceutical Sales
Portfolio Management
Primary Care
Product Launch
Public Speaking
Rheumatology
Sales
Sales Effectiveness
Sales Presentations
Sales Strategy
Salesforce.com
Solution Selling
Territory Account Management
Territory Development
Territory Management
Vaccines
Women's Health
Management
Buy and Bill
Allergic Rhinitis
Melissa Porter Summary
Melissa Porter, based in Boise, ID, US, is currently a Neuroscience Specialty Representative at Ipsen. Melissa Porter brings experience from previous roles at Hologic, Inc., Cepheid, Roche and Novartis. Melissa Porter holds a Bachelor of Arts - BA @ Louisiana State University. With a robust skill set that includes Account Management, Biotechnology, Building Relationships, Business-to-Business (B2B), Buy & Bill and more. Melissa Porter has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Melissa Porter?
Find contact details for 700 million professionals.